4.7 Article

The Therapeutic Potential of Naturally Occurring Peptides in Counteracting SH-SY5Y Cells Injury

期刊

出版社

MDPI
DOI: 10.3390/ijms231911778

关键词

opioid peptides; 6-hydroxydopamine; neuronal survival; neuroprotection; antioxidant activity; apoptosis

资金

  1. National Science Center (NCN, Miniatura) [DEC2021/05/X/ST5/00294]
  2. PolishNationalAgency forAcademic Exchange [BPN/BPT/2021/1/00053]
  3. Portuguese Foundation for Science and Technology (FCT) [UIDP/04292/2020, UIDB/04292/2020]
  4. Associate Laboratory ARNET [LA/P/0069/2020]
  5. CROSS-ATLANTIC [PTDC/BIA-OUT/29250/2017]
  6. European Regional Development Fund (FEDER), through the Operational Programme for Competitiveness and Internationalization (COMPETE 2020)
  7. Programme for Cooperation in Science between Portugal and Poland through project NEURONS-Natural products as key drivers in the development of nEUropROtective therapeutic ageNtS [FCT/DRI/PNAAE 2021.09608]

向作者/读者索取更多资源

This study investigates the neuroprotective properties of four naturally occurring peptides. The results show that endomorphin-1 and endomorphin-2 can inhibit neuronal cell death induced by 6-hydroxydopamine, reducing mitochondrial membrane potential and Caspase-3 activity. Meanwhile, rubiscolin-6 shows antioxidant potential and can recover neurotoxicity by reducing reactive oxygen species levels and improving mitochondrial function.
Peptides have revealed a large range of biological activities with high selectivity and efficiency for the development of new drugs, including neuroprotective agents. Therefore, this work investigates the neuroprotective properties of naturally occurring peptides, endomorphin-1 (EM-1), endomorphin-2 (EM-2), rubiscolin-5 (R-5), and rubiscolin-6 (R-6). We aimed at answering the question of whether well-known opioid peptides can counteract cell injury in a common in vitro model of Parkinson's disease (PD). Antioxidant activity of these four peptides was evaluated by the 2-diphenyl-1-picrylhydrazyl radical (DPPH) scavenging activity, oxygen radical absorbance capacity (ORAC), and ferric-reducing antioxidant power (FRAP) assays, while neuroprotective effects were assessed in a neurotoxic model induced by 6-hydroxydopamine (6-OHDA) in a human neuroblastoma cell line (SH-SY5Y). The mechanisms associated with neuroprotection were investigated by the determination of mitochondrial membrane potential (MMP), reactive oxygen species (ROS) production, and Caspase-3 activity. Among the tested peptides, endomorphins significantly prevented neuronal death induced by 6-OHDA treatment, decreasing MMP (EM-1) or Caspase-3 activity (EM-2). Meanwhile, R-6 showed antioxidant potential by FRAP assay and exhibited the highest capacity to recover the neurotoxicity induced by 6-OHDA via attenuation of ROS levels and mitochondrial dysfunction. Generally, we hypothesize that peptides' ability to suppress the toxic effect induced by 6-OHDA may be mediated by different cellular mechanisms. The protective effect caused by endomorphins results in an antiapoptotic effect (mitochondrial protection and decrease in Caspase-3 activity), while R-6 potency to increase a cell's viability seems to be mediated by reducing oxidative stress. Our results may provide new insight into neurodegeneration and support the short peptides as a potent drug candidate to treat PD. However, further studies should be conducted on the detailed mechanisms of how tested peptides could suppress neuronal injuries.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据